EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges

Bshra A Alsfouk iD

Therapeutics and Clinical Risk Management · 2026-11 · Volume 22 · 1-17

DOI: 10.2147/tcrm.s652958 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-11. Verfasst von Bshra A Alsfouk. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IBSantidepressantsfunctional gastrointestinal disordersgut-brain neuromodulatorsirritable bowel syndromeselective serotonin reuptake inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

ORCID-Profile: Bshra A Alsfouk

Zitieren

APA

Alsfouk, B. A. (2026). Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges. Therapeutics and Clinical Risk Management, Volume 22, 1-17. https://doi.org/10.2147/tcrm.s652958

Vancouver

Alsfouk BA. Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-17. doi:10.2147/tcrm.s652958

BibTeX
@article{Alsfouk2026,
  author = {Alsfouk, Bshra A},
  title = {Clinical Positioning of Selective Serotonin Reuptake Inhibitors as Gut-Brain Neuromodulators in Irritable Bowel Syndrome: A Comprehensive Review of Mechanisms, Effectiveness, Tolerability, and Treatment Challenges},
  journal = {Therapeutics and Clinical Risk Management},
  year = {2026},
  volume = {Volume 22},
  pages = {1--17},
  doi = {10.2147/tcrm.s652958}
}
Kostenlos starten →